Whole Blood Stimulation Assay as a Treatment Outcome Monitoring Tool for VL Patients in Ethiopia: A Pilot Evaluation

Visceral leishmaniasis (VL) is a lethal disease if left untreated. Current treatments produce variable rates of treatment failure and toxicity without sterile cure, rendering treatment efficacy monitoring essential. To avoid repeated invasive tissue aspirates as well as empirical treatment, there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Aleka, Yetemwork, Ibarra-Meneses, Ana Victoria, Workineh, Meseret, Tajebe, Fitsumbrhan, Kiflie, Amare, Tessema, Mekibib Kassa, Melkamu, Roma, Tadesse, Azeb, Moreno, Javier, van Griensven, Johan, Carrillo, Eugenia, Adriaensen, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193677/
https://www.ncbi.nlm.nih.gov/pubmed/32377538
http://dx.doi.org/10.1155/2020/8385672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193677/
https://www.ncbi.nlm.nih.gov/pubmed/32377538
http://dx.doi.org/10.1155/2020/8385672

Ejemplares similares